Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Huihui He
Institution:
Wuxi Fourth People's Hospital
Observed institution:
Wuxi Fourth People's Hospital
ORCID:
0000-0001-8127-6671
Observed ORCID:
0000-0001-8127-6671
OpenAlex ID:
A5026964506
EDB-FN targeted probes for the surgical navigation, radionuclide imaging, and therapy of thyroid cancer
2023
·
Ruping Li
, Huihui He
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
13
PDF
A liver-targeting magnetic iron oxide nanoparticle-based dual-modality probe for PET/MR imaging of liver tumor
2024
·
Qiaoling Shen
, Jialiang Wang
, et al.
·
Colloids and Surfaces A Physicochemical and Engineering Aspects
·
12
Preliminary evaluation of a novel PSMA-targeting radiopharmaceutical [68Ga]Ga/[177Lu]Lu–NYM032 for theranostic use in prostate cancer
2025
·
Haitian Fu
, Huihui He
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
8
Noninvasive Imaging of Claudin 18.2 Expression in Gastric Adenocarcinoma: Synthesis, Preclinical Evaluation, and Preliminary Clinical Study of a Novel [89Zr]Zr-DFO-NY005 Immuno-Positron Emission Tomography Tracer
2025
·
Jialiang Wang
, Kequan Lou
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
2
Synthesis and biological evaluation of a novel 68Ga-labeled GalNAc-PET probe for asialoglycoprotein receptor imaging
2024
·
Yuqi Hua
, Huihui He
, et al.
·
Colloids and Surfaces A Physicochemical and Engineering Aspects
·
2
A phase Ia study to estimate the radiochemical and radiation safety of of 68 Ga-NYM032, a PSMA-targeted radioligand.
2025
·
Si Yang
, Haitian Fu
, et al.
·
Journal of Clinical Oncology
PDF
Phase I/II trial of 177 Lu-NYM032 for progressive metastatic castration-resistant prostate cancer.
2025
·
Peng Fang
, Waisi Eng
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
7
Citation count:
37
H-index:
3
I10-index:
2
Year
Topic
Type